PFIZER INC (PFE)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for PFE
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| PFE | Chief Scientific Officer and President | ["Led the transformation of Pfizer’s global R&D organization","Enhanced strategic focus, operational excellence and scientific productivity","Unified Pfizer’s global R&D organization","Established four end-to-end R&D units","Achieved transformative business development and AI-driven innovation"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Chris Boshoff, M.D., Ph.D., FRCP, FMedSci, serves as the Chief Scientific Officer and President of Research & Development at Pfizer Inc. In his role, Boshoff is responsible for integrating R&D across various therapeutic areas, a critical function that ensures the company's innovative efforts are cohesive and impactful. He has been instrumental in strengthening Pfizer's Oncology R&D, contributing significantly to the company's success in this area. Under his leadership, Pfizer achieved $11.6 billion in U.S. Oncology revenues, a testament to his strategic vision and execution capabilities.
Boshoff's achievements at Pfizer extend beyond financial success. He successfully oversaw the integration of Seagen into Pfizer, a move that bolstered the company's oncology portfolio and capabilities. His leadership has also resulted in the delivery of five regulatory approvals and nine first-in-patient milestones, showcasing his ability to drive innovation and bring new treatments to patients in need. Boshoff's expertise and dedication have made him a key figure in Pfizer's ongoing efforts to advance healthcare solutions globally.
Prior to his role at Pfizer, Chris Boshoff had a distinguished career in the medical and scientific fields. He holds an M.D. and a Ph.D., and is a Fellow of the Royal College of Physicians (FRCP) and a Fellow of the Academy of Medical Sciences (FMedSci). These accolades reflect his deep knowledge and contributions to medicine and science. At Pfizer, Boshoff is not an independent board member, as he holds an executive position within the company. His role as a non-independent board advisor allows him to directly influence the company's strategic direction, particularly in the areas of research and development.
In addition to his work at Pfizer, Boshoff is recognized in the broader scientific community for his contributions to oncology research. His career is marked by a commitment to advancing cancer treatments and improving patient outcomes, a mission that continues to drive his work at Pfizer. As the company navigates the complexities of the pharmaceutical industry, Boshoff's leadership and scientific expertise will undoubtedly play a crucial role in shaping its future successes.